Consumption of antidepressants in Chile from 1992 to 2004 Consumo de antidepresivos en Chile entre 1992 y 2004
Author
dc.contributor.author
Jrón, Marcela
Author
dc.contributor.author
Machado, Márcio
Author
dc.contributor.author
Ruiz, Inés
Admission date
dc.date.accessioned
2019-03-11T12:56:45Z
Available date
dc.date.available
2019-03-11T12:56:45Z
Publication date
dc.date.issued
2008
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 136, Issue 9, 2018, Pages 1147-1154
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164654
Abstract
dc.description.abstract
Background: Data from the Mnistry of Health show that in Chile in 2004, 17% of the population had some form of depresdon and mood disorders are the tenth cause of disability-adjusted life years (DALY) loss. Aim: To determine consumption of antidepressants (ADs) in Chile from 1992 to 2004. Material and methods: National sales data were obtained from the company IMS Health Chile and converted into defined daily doses (DDDs) per 1,000 inhabitants per day. Available ADs were classified in four pharmacological, groups (i.e., serotonin-norepinephrine reuptake inhibitors, SNRIs; selective-serotonin reuptake inhibitors, SSRIs; tricyclic antidepressants, TCAs; and others). Total economic burden of ADs utilization and cost per DDDs were also calculated. Trends over time were analyzed using Pearson-R2. Results: Total ADs consumption in Chile measured by DDDs per 1,000 inhabitants per day (DHD) increased linearly (y =0.901x+1.9129; R2 =0.9296; p <0.001) from 2.5 in 1992 to 11.7 in 2004 (total grow